INDICATED FOR THE TREATMENT OF CHRONIC STABLE ANGINA (CLASSIC EFFORT-ASSOCIATED ANGINA). BECAUSE BEPRIDIL HAS CAUSED SERIOUS VENTRICULAR ARRHYTHMIAS, INCLUDING TORSADES DE POINTES TYPE VENTRICULAR TACHYCARDIA, AND THE OCCURRENCE OF CASES OF AGRANULOCYTOSIS ASSOCIATED WITH ITS USE, IT SHOULD BE RESERVED FOR PATIENTS WHO HAVE FAILED TO RESPOND OPTIMALLY TO, OR ARE INTOLERANT OF OTHER ANTI-ANGINAL MEDICATION.
STARTING DOSE IS 200 MG ONCE DAILY. AFTER 10 DAYS, BECAUSE STEADY-STATE BLOOD LEVELS ARE NOT ACHIEVED UNTIL 8 DAYS, DOSAGE MAY BE ADJUSTED UPWARD DEPENDING UPON THE PATIENT'S RESPONSE (E.G., ABILITY TO PERFORM ACTIVITIES OF DAILY LIVING, QT INTERVAL, HEART RATE, AND FREQUENCY AND SEVERITY OF ANGINA). MINIMUM EFFECTIVE DOSE IS 200 MG/DAY & MAXIMUM DOSE IS 400 MG/DAY.